USC.edu
Are You a Patient?

Deepa Bhojwani, MBBS, DCH

Associate Professor of Clinical Pediatrics

Image of Deepa Bhojwani, MBBS, DCH
Is this your profile? Click to edit
Email dbhojwani@chla.usc.edu
CTSI Profile

Publications

  • Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial. Haematologica. 2025 Dec 01; 110(12):2930-2941.. View in PubMed
  • Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report. Blood Adv. 2025 Nov 25; 9(22):5738-5751.. View in PubMed
  • Biophysically constrained dynamical modelling of the brain using multimodal magnetic resonance imaging. Brain Res Bull. 2025 Oct 15; 231:111541.. View in PubMed
  • Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies. Blood. 2025 Sep 04; 146(10):1163-1173.. View in PubMed
  • Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial. Pediatr Blood Cancer. 2025 May; 72(5):e31584.. View in PubMed
  • Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity. Clin Pharmacol Ther. 2025 Mar; 117(3):724-731.. View in PubMed
  • Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patients. Pharmacogenet Genomics. 2025 Feb 01; 35(2):73-80.. View in PubMed
  • CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells. Blood Cancer Discov. 2025 Jan 08; 6(1):55-72.. View in PubMed
  • Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia. Pediatr Res. 2025 Jan; 97(1):348-359.. View in PubMed
  • Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype. Leuk Lymphoma. 2024 Dec; 65(12):1840-1852.. View in PubMed
  • Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium. J Natl Cancer Inst. 2024 Nov 01; 116(11):1721-1729.. View in PubMed
  • Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study. Leukemia. 2024 Nov; 38(11):2382-2394.. View in PubMed
  • Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study. Br J Haematol. 2024 Oct; 205(4):1450-1459.. View in PubMed
  • Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial. Res Sq. 2024 Aug 05.. View in PubMed
  • Development of second genetically distinct T-lymphoblastic leukemia in a pediatric patient. Pediatr Blood Cancer. 2024 Aug; 71(8):e31050.. View in PubMed
  • IKZF1PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Jul; 71(7):e30996.. View in PubMed
  • Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations. J Natl Cancer Inst. 2024 May 08; 116(5):702-710.. View in PubMed
  • B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with ETV6 thrombocytopenia and leukemia predisposition syndrome: novel clinical presentation and perspective. Haematologica. 2024 05 01; 109(5):1624-1627.. View in PubMed
  • Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Cancers (Basel). 2024 Jan 24; 16(3).. View in PubMed
  • Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children’s Oncology Group. J Clin Oncol. 2024 Jan 10; 42(2):218-227.. View in PubMed
  • INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 01; 30(1):56-70.. View in PubMed
  • Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory. J Mol Diagn. 2024 01; 26(1):49-60.. View in PubMed
  • Children’s Oncology Group blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30585.. View in PubMed
  • Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure. Transplant Cell Ther. 2023 09; 29(9):574.e1-574.e10.. View in PubMed
  • Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population. Br J Haematol. 2023 07; 202(1):e3-e6.. View in PubMed
  • Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 05; 37(5):1138-1140.. View in PubMed
  • Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells. Blood Adv. 2023 02 28; 7(4):575-585.. View in PubMed
  • Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood Adv. 2023 02 28; 7(4):602-610.. View in PubMed
  • Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia. Front Cell Dev Biol. 2023; 11:1134121.. View in PubMed
  • Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert Opin Drug Metab Toxicol. 2023 Jan-Jun; 19(6):357-366.. View in PubMed
  • Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 10; 69(10):e29812.. View in PubMed
  • Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy. Blood Adv. 2022 09 13; 6(17):5222-5226.. View in PubMed
  • Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping. Blood Adv. 2022 06 14; 6(11):3343-3346.. View in PubMed
  • Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia. Biomed Pharmacother. 2022 Jun; 150:113000.. View in PubMed
  • Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype. Blood. 2022 05 26; 139(21):3159-3165.. View in PubMed
  • Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. Am J Hematol. 2022 05; 97(5):613-622.. View in PubMed
  • Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children’s Oncology Group Protocol AALL1621. J Clin Oncol. 2022 03 20; 40(9):956-967.. View in PubMed
  • Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL. J Clin Oncol. 2022 03 20; 40(9):932-944.. View in PubMed
  • In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia. Exp Ther Med. 2022 Jan; 23(1):47.. View in PubMed
  • Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis. Cancer Genet. 2022 01; 260-261:37-40.. View in PubMed
  • Managing therapy-associated neurotoxicity in children with ALL. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):376-383.. View in PubMed
  • SINGLE INJECTION RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION: Incidence and Characteristics. Retina. 2021 Sep 01; 41(9):1901-1910.. View in PubMed
  • Antibody-Drug Conjugates for the Treatment of Acute Pediatric Leukemia. J Clin Med. 2021 Aug 13; 10(16).. View in PubMed
  • Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparity. Leukemia. 2021 08; 35(8):2399-2402.. View in PubMed
  • Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics. S D Med. 2021 Jul; 74(7):294-301.. View in PubMed
  • Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematol. 2021 Jul; 8(7):e513-e523.. View in PubMed
  • Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies. Cancer. 2021 06 15; 127(12):2074-2082.. View in PubMed
  • A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies. Cancer Genet. 2021 06; 254-255:25-33.. View in PubMed
  • Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine. 2021 May; 67:103355.. View in PubMed
  • Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv. 2021 Mar 02.. View in PubMed
  • Current intravitreal therapy and ocular hypertension: A review. Indian J Ophthalmol. 2021 02; 69(2):236-243.. View in PubMed
  • Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 01; 68(1):e28574.. View in PubMed
  • Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Front Oncol. 2021; 11:766888.. View in PubMed
  • Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia. Cancer. 2020 11 01; 126(21):4800-4805.. View in PubMed
  • Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL. J Pediatr Hematol Oncol. 2020 11; 42(8):e839-e844.. View in PubMed
  • Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy. Leukemia. 2020 08; 34(8):2271-2275.. View in PubMed
  • Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020 07 09; 136(2):210-223.. View in PubMed
  • Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study. Clin Cancer Res. 2020 05 15; 26(10):2297-2307.. View in PubMed
  • Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 05; 67(5):e28112.. View in PubMed
  • Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity. Proc Natl Acad Sci U S A. 2020 03 10; 117(10):5394-5401.. View in PubMed
  • Intravitreal dexamethasone implant as an alternative to systemic steroids as prophylaxis for uveitic cataract surgery: a randomized trial. Eye (Lond). 2020 03; 34(3):491-498.. View in PubMed
  • Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab. J Ophthalmol. 2020; 2020:7462098.. View in PubMed
  • ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia. Clin Cancer Res. 2020 01 01; 26(1):256-264.. View in PubMed
  • Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study. Ophthalmol Retina. 2019 11; 3(11):929-937.. View in PubMed
  • Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia. Blood Adv. 2019 07 09; 3(13):1926-1929.. View in PubMed
  • Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 Apr; 33(4):1061-1062.. View in PubMed
  • Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. Leukemia. 2019 04; 33(4):884-892.. View in PubMed
  • Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3052-3061.. View in PubMed
  • INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION. Retina. 2018 Dec; 38(12):2343-2349.. View in PubMed
  • The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. AJNR Am J Neuroradiol. 2018 10; 39(10):1919-1925.. View in PubMed
  • Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr Blood Cancer. 2018 09; 65(9):e27265.. View in PubMed
  • Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Blood Cancer J. 2018 08 22; 8(9):80.. View in PubMed
  • Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia. Thromb Res. 2018 05; 165:44-50.. View in PubMed
  • Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. Pediatr Blood Cancer. 2018 03; 65(3).. View in PubMed
  • Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018 Feb; 65(2).. View in PubMed
  • Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia. Blood. 2017 10 05; 130(14):1620-1627.. View in PubMed
  • A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia. Cancer Genet. 2017 Oct; 216-217:91-99.. View in PubMed
  • The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9).. View in PubMed
  • Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group. Pediatr Hematol Oncol. 2017 Sep – Oct; 34(6-7):355-364.. View in PubMed
  • Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Res. 2017 02; 27(2):185-195.. View in PubMed
  • Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. J Clin Oncol. 2016 12 20; 34(36):4381-4389.. View in PubMed
  • Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series. Eye (Lond). 2016 Dec; 30(12):1549-1557.. View in PubMed
  • Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol. 2016 Oct; 3(10):e456-e466.. View in PubMed
  • The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2016 09; 63(9):1546-51.. View in PubMed
  • Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. J Clin Oncol. 2016 06 20; 34(18):2133-40.. View in PubMed
  • NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016 Apr; 48(4):367-73.. View in PubMed
  • In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.. View in PubMed
  • NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat Genet. 2015 Jun; 47(6):607-14.. View in PubMed
  • Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol. 2015 Apr; 16(4):465-74.. View in PubMed
  • The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol. 2015 Mar; 168(6):845-53.. View in PubMed
  • Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol. 2015 Feb 20; 33(6):610-5.. View in PubMed
  • Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015 Feb; 62(1):47-60.. View in PubMed
  • A revised definition for cure of childhood acute lymphoblastic leukemia. Leukemia. 2014 Dec; 28(12):2336-43.. View in PubMed
  • Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer. 2014 Oct; 50(15):2685-94.. View in PubMed
  • A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. J Pediatr Hematol Oncol. 2014 Aug; 36(6):458-63.. View in PubMed
  • Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics. 2014 Jun; 15(8):1065-78.. View in PubMed
  • Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer. 2014 May 15; 120(10):1514-9.. View in PubMed
  • Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014 Mar 20; 32(9):949-59.. View in PubMed
  • Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013 Dec; 45(12):1494-8.. View in PubMed
  • HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma. 2013 Nov; 54(11):2565-7.. View in PubMed
  • A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet. 2013 Oct; 45(10):1226-1231.. View in PubMed
  • Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children’s Research Hospital from 1962 to 2002. Ann Oncol. 2013 Sep; 24(9):2425-9.. View in PubMed
  • Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013 Jun 10; 31(17):2182-8.. View in PubMed
  • Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia. Cancer. 2013 Jun 01; 119(11):2061-6.. View in PubMed
  • Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013 May 15; 105(10):733-42.. View in PubMed
  • Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013 May; 14(6):e205-17.. View in PubMed
  • Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia. Methods Mol Biol. 2013; 999:273-84.. View in PubMed
  • Endogenous knockdown of survivin improves chemotherapeutic response in ALL models. Leukemia. 2012 Feb; 26(2):271-9.. View in PubMed
  • ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia. 2012 Feb; 26(2):265-70.. View in PubMed
  • Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling. Blood. 2012 Jan 19; 119(3):817-25.. View in PubMed
  • Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol. 2012 Jan; 156(2):275-9.. View in PubMed
  • Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011 Nov 10; 118(19):5218-26.. View in PubMed
  • Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia. 2011 Oct; 25(10):1555-63.. View in PubMed
  • Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol. 2011 Sep; 90(9):1067-74.. View in PubMed
  • Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol. 2011 Feb 01; 29(4):386-91.. View in PubMed
  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010 Dec 02; 116(23):4874-84.. View in PubMed
  • Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia. Br J Haematol. 2010 Aug; 150(3):352-8.. View in PubMed
  • Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 2010 Feb 18; 115(7):1394-405.. View in PubMed
  • Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010 Feb; 24(2):371-82.. View in PubMed
  • High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S222-30.. View in PubMed
  • Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008 Nov 15; 112(10):4178-83.. View in PubMed
  • Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children’s Oncology Group Study [corrected]. J Clin Oncol. 2008 Sep 20; 26(27):4376-84.. View in PubMed
  • T-cell PTLD presenting as acalculous cholecystitis. Pediatr Transplant. 2008 Sep; 12(6):717-20.. View in PubMed
  • Intrathecal liposomal cytarabine: more friend than foe? Leuk Lymphoma. 2008 Aug; 49(8):1427-30.. View in PubMed
  • Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia. Paediatr Drugs. 2007; 9(3):149-56.. View in PubMed
  • Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006 Aug; 47(2):130-40.. View in PubMed
  • Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood. 2006 Jul 15; 108(2):711-7.. View in PubMed
  • Childhood acute lymphoblastic leukemia in the age of genomics. Pediatr Blood Cancer. 2006 May 01; 46(5):570-8.. View in PubMed
  • Individualized therapy for childhood acute lymphoblastic leukemia. Per Med. 2005 Nov; 2(4):349-361.. View in PubMed
  • Thrombophilia in childhood. Curr Probl Pediatr Adolesc Health Care. 2004 May-Jun; 34(5):190-212.. View in PubMed
  • Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2003; 102-31.. View in PubMed

Similar People